MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells
Ontology highlight
ABSTRACT: The steroid co-activator protein SRC-1 plays an important role in endocrine therapy resistant breast cancer. Its expression is associated with large high grade tumours, HER2 positivity, disease recurrence and resistance to endocrine therapy. While SRC-1 typically functions to activate gene expression, some evidence has pointed towards a potential role in repression. This study looks into the effects of a stable knockdown of SRC-1 in a tamoxifen resistant cell line, LY2, and the effects of this knock down on the methylation landscape.
ORGANISM(S): Homo sapiens
PROVIDER: GSE99648 | GEO | 2018/06/04
REPOSITORIES: GEO
ACCESS DATA